Study S000406

Tirzepatide Versus Positive Airway Pressure for the Treatment of Obstructive Sleep Apnoea: A Randomised Comparative Effectiveness Trial

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record

Registration

Registration: NCT07846865
Acronym: TIRZE-PAP
Study type: INTERVENTIONAL
Allocation: RANDOMIZED
Phase: PHASE2; PHASE3
Masking: NONE
Status: NOT_YET_RECRUITING
Enrollment: 256
Start: 2026-10-01
Primary completion: 2028-12-01
Lead sponsor: Woolcock Institute of Medical Research
Conditions: Sleep Apnoea; Obesity & Overweight; Sleep Apnea Syndrome, Obstructive
Interventions: DEVICE:Continuous Positive Airway Pressure; DRUG:Tirzepatide
Results posted: FALSE
Individual participant data sharing: YES

Registered primary outcomes

Breathing Disturbance Index (BDI) [The mean BDI measured over 28 nights of monitoring is calculated for baseline (Weeks -4 to 0) and follow-up (Weeks 48 to 52)]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.